Marino Garcia serves as Executive at Dianthus Therapeutics, Inc. /DE/, where they oversee executive responsibilities. Since joining the company, Marino Garcia has executed 1 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Feb 3, 2026 involved receiving (via award) 355,000 shares valued at $0.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| Feb 3, 2026 | DNTH | $0 | Award | 355,000 | $N/A | Discretionary |
Marino Garcia currently holds 355,000 shares of Dianthus Therapeutics, Inc. /DE/ (DNTH), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Marino Garcia has been a net neutral trader of DNTH stock. They have purchased $0 and sold $0 worth of shares.
Marino Garcia's most recent insider trade was on Feb 3, 2026, when they sold 355,000 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted